We found that FGF1 ameliorates diabetes‐induced hepatocyte apoptosis and elevated inflammation via suppressing RAGE expression, suggesting RAGE may be a potential therapeutic target for the treatment of DMLD. The gene discussed is FGF1; the disease is diabetes mellitus.